Skip to content

Effect of Mineralocorticoid on Brown Fat in Humans with Primary Aldosteronism who will be treated with Surgery

Effect of Mineralocorticoid on Brown Fat in humans with primary aldosteronism who will be treated with surgery

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12614001129673
Enrollment
12
Registered
2014-10-23
Start date
2015-01-15
Completion date
2017-06-30
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Brown Fat, unlike ordinary 'white fat', functions like generators, burning fat to produce heat and dissipate energy. Brown fat protects animals against cold and from developing obesity. In humans, it was previously believed that brown fat disappears after infancy. However, research including our own has shown that brown fat is present in most if not all adult humans and is located mainly around the neck. Brown fat activity in humans is detected by a PET scan based on uptake of glucose that is tagged with a small amount of radioactivity. This is a widely used diagnostic method in medicine. Brown fat is more abundant in lean than in obese individuals. Stimulating its activity may be a simple way of controlling body weight in humans. Apart from the cold exposure, very little is known about what regulates brown fat in humans. Our research aims to identify factors that regulates brown fat in humans. Aldosterone is a mineralocorticoid hormone produced from the adrenal glands. In animals, it was found that aldosterone suppresses the activity of brown fat. In this study, we will study in humans whether aldosterone suppresses brown fat activity and removal of aldosterone-producing tumor by surgery reactivates brown fat activity, and whether the changes in brown fat activity is associated with changes in energy expenditures.

Interventions

Newly diagnosed primary aldosteronism who will be treated with surgical removal of the affected adrenal gland. Brown fat activity (using PET-CT scan) and energy expenditures (using indirect calorimetry) will be assessed before and at least 4 weeks after the surgery.

Sponsors

Professor Ken Ho
Lead SponsorIndividual

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

subjects with newly diagnosed primary aldosteronism who will be treated with surgery

Exclusion criteria

Pregnancy

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026